Daishin Securities

Refresh

Top Picks Only

bullish•Samsung Biologics

•26 Apr 2024 19:01•Broker

Samsung Biologics - Decent Earnings, Successful Contract Wins in Q1

1Q24 reports consolidated revenue of W946.9bn(+31% yoy), OP of W221.3bn (+15% yoy). Beat consensus owing to an increase in plant 4 operation rate...

327 Views

bullish•Naver Corp

•19 Apr 2024 19:04•Broker

Naver (035420 KS Apr 17, 2024) - Too Much Concerns, Even Considering China

Strong core business (advertising/commerce) performance expected in 1Q24. Need to watch China’s active commerce market expansion

Founded in 1962, Daishin Securities is a leading financial services provider in Korea. Daishin securities does its best to provide high quality financial service and to satisfy the various needs of investors. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Sm...